LSA
FUSN

Leonteq Securities AG’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Leonteq Securities AG’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-35,000
Closed -$91K – 1307
2023
Q3 		$91K Hold
35,000
– – 0.01% 672
2023
Q2 		$164K Hold
35,000
– – 0.01% 574
2023
Q1 		$132K Sell
35,000
-18,000
-34% -$70.9K 0.01% 600
2022
Q4 		$167K Buy
+53,000
New +$132K 0.01% 574

Other funds holding FUSN

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Leonteq Securities AG's FUSN Position: Q4 2023 in Review

Leonteq Securities AG sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q4 2023, closing a stake of 35,000 shares — an estimated $91K sold.

Leonteq Securities AG first reported a position in FUSN in Q4 2022 and held it in 4 quarters. The position peaked at $167K in Q4 2022. 77 funds tracked by Wall St. Rank hold FUSN as of Q4 2023.

  • Leonteq Securities AG reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q4 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 35,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q4 2023, an estimated $91K.
  • Leonteq Securities AG first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2022 and held it in 4 quarters.
  • Leonteq Securities AG's Fusion Pharmaceuticals Inc. Common Shares position peaked at $167K in Q4 2022.
  • 77 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q4 2023.

Based on Leonteq Securities AG's 13F filing for Q4 2023, filed 11 Mar 2026.